Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone

BACKGROUND: Radiographic progression-free survival (rPFS) is associated with overall survival (OS) in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients. Using readily assessable baseline clinical and laboratory parameters, we developed a prognostic index model for r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Genitourin Cancer
Main Authors: Ryan, Charles J., Kheoh, Thian, Li, Jinhui, Molina, Arturo, De Porre, Peter, Carles, Joan, Efstathiou, Eleni, Kantoff, Philip W., Mulders, Peter F.A., Saad, Fred, Chi, Kim N.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5785489/
https://ncbi.nlm.nih.gov/pubmed/28844792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2017.07.014
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares